home
team
ALUMNI
PROJECTS
PUBLICATIONS
EVENTS
NEWS
Contact
PUBLICATIONS
Identifying drug sensitivity of multifocal primary prostate cancer
Bladder cancer organoids as a functional system to model different disease stages and therapy response
Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer
Role of prostate and bone stromal cells on prostate cancer progression
Bladder Cancer organoids as a functional system to model different disease stages and therapy response
Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
Patient-derived xenografts and organoids model therapy response in prostate cancer
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Genitourinary cancer treatment made personal
Patient-derived xenografts and organoids model therapy response in prostate cancer
Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.
A NF-ĸB-Activin A signaling axis enhances prostate cancer metastasis.
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Metastases in Prostate Cancer.
CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Correction to: Store-Operated Ca2+ Entry as a Prostate Cancer Biomarker - a Riddle with Perspectives.
ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.
CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy.
A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response.
Store-Operated Ca2+ Entry as a Prostate Cancer Biomarker - a Riddle with Perspectives.
Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease).
Mouse models for studying prostate cancer bone metastasis.
Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors.
Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in mice.
